Man's horror ‘locked in' syndrome after error
Jonathan Buckelew, 34, has been awarded a staggering $75 million (AU $116 million) in damages after multiple physicians failed to diagnose his life-threatening stroke, leaving him paralysed from head to toe for the rest of his life.
Jonathan was rushed to North Fulton Hospital on October 26, 2015, after falling unconscious during a chiropractic neck adjustment, New York Post reported.
Despite the emergency response, almost every physician who came into contact failed to clock Jonathan's stroke.
Their lackadaisical care led the patient in his mid-20s to develop horrific locked-in syndrome, leaving him unable to move or talk despite having full consciousness.
'This case is heartbreaking because Jonathan's paralysis and brain damage were completely avoidable,' said Jonathan's lawyer, Lloyd Bell, in a statement made following the Georgia Court of Appeals' decision to uphold a verdict in their favour last March.
'If the slew of healthcare providers involved in Jonathan's care would have acted according to the standard of care, caught and treated his stroke earlier, and communicated more effectively, Jonathan's life would look entirely different.'
The Buckelews sued the chiropractor, the hospital, Dr. Matthew Womack, radiologist James Waldschmidt and neurologist Christopher Nickum for their failure to catch Jonathan's stroke — the rapid treatment of which could have prevented his tragic outcome.
A Fulton County state court found Womack and Waldschmidt guilty of malpractice, ordering the former to hand over $40 million. Jonathan was ultimately awarded $29 million in past and future medical expenses and $46 million for pain and suffering, per court documents.
Jonathan is now restricted to communication through eye movements and a keypad that he manages to use with his nose.
His parents, Jack and Janice, have turned their home into a 24-hour care centre for their debilitated son.
'I really feel like there's no real justice for somebody who lost every aspect of his life,' Jack, told CBS affiliate Atlanta News First.
'He wants to do things, he wants to go places — it just breaks our heart to see him like he is,' the desperate father continued.
'There are some days where he's like 'pull the plug,' so those are the tough days.'
Jonathan's counsel has blamed the hospital staff for not following standard procedure.
'The ER doctor saw this patient was having all these signs and symptoms of stroke and never called a stroke alert, and they had policies in place that they were supposed to follow certain protocols to reach the correct diagnosis, and they didn't follow their policies and procedures,' Bell said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
6 hours ago
- News.com.au
Bindi Irwin shares life-changing health update after decade-long battle
Bindi Irwin has given a heartwarming update in her long battle with endometriosis following her diagnosis in 2023, which came after a decade of chronic pain. In a post on Instagram, Bindi went into detail about her years-long struggle and revealed that after her latest surgery she is 'finally' beginning to feel like she is 'healing' for the first time. '51 endometriosis lesions, a cyst, and my appendix were all removed across two surgeries with @seckinmd. My hernia from giving birth that was unzipping - was taken care of. I can FINALLY say that I'm feeling better. Genuinely healing.' Bindi previously underwent emergency surgery in May, which meant she missed a gala honouring her late father. 'I can function in everyday life without wanting to throw up or pass out from the pain. Slowly, slowly gaining my strength back,' her latest post continued. 'I cannot express the gravity of my emotions as I am beginning to recognise myself again. 'I felt utterly ashamed as a teenager and young adult being told that my pain was just part of being a woman. 'I felt lesser. I felt hurt. I felt weak. That is not OK.' She concluded: 'Young girls and women shouldn't feel alone with pain in the driver's seat of their lives. 'We need to take away the stigma of talking about women's health. It's time to have open discussions and make change on a global scale.' Last year, Bindi shared that she had been suffering for years with endometriosis. Her story quickly resonated with hundreds of thousands of other Aussie women who had been struggling in silence. While she was nervous to open up publicly, she's now grateful she was brave enough to do so. 'It is scary when you open up about your most vulnerable and painful times, when you talk about when you felt you were sitting in a very large hole and didn't know if you were going to crawl out,' she told Courier Mail. Before she shared her story, Bindi revealed that she struggled with people judging her without being aware of the battle she was fighting privately. 'It took me so long to talk about it, nobody knew what was happening to me except my mum (Terri Irwin), my brother Robert and my husband Chandler (Powell). 'Everyone else thought I was becoming this flaky person because I would bow out of commitment after commitment at the last minute because I was in so much pain,' she added before explaining how uncomfortable she was with being asked when she planned on having more children. 'When I went through endo and people would ask, 'When are you and Chandler having another child?' I used to think, 'If you could see on the outside what it feels like on the inside you would never ask.' It would completely change the way you approach somebody. 'You know, some people don't want another child, some can't have another child, and some people have gone through enormous loss and heartbreak before they have their much wanted child.'
ABC News
7 hours ago
- ABC News
Coroner finds grandmother Margaret Mariani's death at Forster Private Hospital preventable
A coroner has found the death of an 88-year-old grandmother at a New South Wales private hospital was preventable. Margaret Mariani died on July 14, 2019 at Manning Base Hospital in Taree on the state's mid north coast from complications following a gall bladder removal at Forster Private Hospital two days earlier. Deputy State Coroner Joan Baptie said Forster Private Hospital's treatment of Mrs Mariani was "grossly inadequate" when she delivered her findings on Thursday, following an inquest into the 88-year-old's death held in February. "[Mrs Mariani] was entitled to the highest level of care and treatment when she was admitted … the resulting care and treatment was significantly deficient," Magistrate Baptie said. Magistrate Baptie said Mrs Mariani's daughter, Karyn Hemming, repeatedly flagged concerns with healthcare staff about her mother's significant pain a day after the surgery. Ms Hemming said in a statement she often woke in the middle of the night thinking about her mother's death. "I hope that the medical staff will take concerns of families seriously in the future." Magistrate Baptie found the 88-year-old's pain had not been properly recorded or referred to doctors by the registered nurse overseeing her care. Magistrate Baptie said she died as a result of a steady deterioration in her physical presentation in circumstances where there would have been earlier signs of peritonitis. She said if Mrs Mariani's symptoms had been investigated at the request of her daughter on the morning of July 13, it was likely she could have been re-admitted to theatre for inflammation of her peritoneum. "Mrs Mariani's death was preventable," she said. "The lack of professional review of the systemic issues by Forster Private Hospital are significantly concerning in terms of the health and safety of potential or future patients." The registered nurse, who cannot be named for legal reasons, has been referred by the Coroner's Court to the state's Health Care Complaints Commission and the Nursing and Midwifery Board of Australia. In her findings, Magistrate Baptie provided two recommendations to Forster Private Hospital to amend its policies and procedures to bolster patient care as well as provide further training for all staff. Magistrate Baptie told the court she would be sending her inquest findings to the NSW Ministry of Health and Minister for Health Ryan Park. "Our sympathies go to the family of Margaret Mariani," a statement from Minister Park said. "NSW Health will consider the findings of the coroner carefully." Forster Private Hospital declined to comment on the findings. Mrs Mariani's son, Michael Easson AM, said in a statement the family was exhausted after six years but was grateful to the coroner for her investigation and findings. "We wanted to yield the truth about what happened and to learn lessons about what went wrong so that Mum's community in Forster will not have this happen again," he said.
The Australian
11 hours ago
- The Australian
Argenica brain drug paces for FDA clearance
FDA provides clear path for Argenica to lift clinical hold on its ARG-007 stroke drug Further clarification on safety of dose in humans and three additional in vitro lab studies requested Company confident studies are straightforward and can be completed quickly Special Report: Argenica Therapeutics now has a clear path forward to clear the clinical hold currently in place on its investigational new drug application that will enable clinical trials for its lead drug ARG-007. In its full letter, the US Food and Drug Administration (FDA) requested additional information to provide assurance that proposed dosing for a US trial of ARG-007 in acute ischaemic stroke can be achieved safely in humans. The FDA has also requested that Argenica Therapeutics (ASX:AGN) conduct three additional in vitro cell culture studies with clinical research organisations to address identified gaps in data. AGN plans to use safety data from its Phase 2 acute ischaemic stroke trial, which will be available in September, as part of its response to the FDA's request for safety assurance. It adds that three additional studies are small ones that can be completed quickly and build on existing data it has already generated. 'We are pleased to have received the clarification from the FDA as to the additional information required to progress the IND application,' managing director Dr Liz Dallimore said. 'Importantly from a timing and cost perspective, the requested additional in vitro assays are standard assays which are straightforward and efficient to perform. 'Argenica will work with the FDA to ensure the proposed approach to providing the additional information is adequate to lift the clinical hold.' Preventing brain injury During acute neurological events such as stroke, traumatic brain injury (TBI), and hypoxic brain damage, around 1.9 million brain cells die for every minute that blood flow is halted. AGN's ARG-007 is a synthetic peptide designed to protect brain cells from dying in the critical minutes and hours by protecting brain tissue during and after these events. The company noted it was targeting acute ischaemic stroke as many patients that experienced it had a thrombectomy, where a radiologist inserts a catheter through the wrist or groin and guides it up into the brain to physically remove a clot. However, this process has the risk of reperfusion injury, which occurs when blood flow rapidly returns to previously oxygen-deprived brain tissue after a clot is removed and potentially causes additional damage. Dosing of patients in a double-blinded, randomised, placebo-controlled Phase 2 trial of ARG-007 in acute ischaemic stroke patients was completed in April. This involved 92 patients presenting to eight emergency departments around Australia with data-read out due in September with safety the main endpoint. The secondary endpoint for the trial will examine efficacy, with a brain scan taken 48 hours post administration of either the placebo or ARG-007. ARG-007 would be the first neuroprotective drug on the global market if approved, tapping into a large addressable global market for stroke and potentially other indications. The global stroke management market was valued at $36.1 billion in 2022, and is projected to reach $74 bn by 2032, driven by several factors including a growing ageing population. There are more than 45,000 strokes annually in Australia and 795,000 in the US – the world's largest healthcare markets. This article was developed in collaboration with Argenica Therapeutics, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
